Gensler and CME Escalate War on Prediction Markets

Why It Matters

Opposition from Gensler — who led the SEC from 2021 to January 2025 and retains considerable Washington credibility — signals that pushback against prediction markets is no longer confined to niche regulatory circles. The CME's involvement is commercially significant: as the world's largest derivatives exchange, its challenge carries legal and lobbying firepower that smaller critics lack. Together, according to iGaming Business, these two voices extend a growing list of CFTC opponents who argue prediction markets blur the line between regulated derivatives and unregulated gambling. For operators and investors building on prediction-market infrastructure, the regulatory outlook is materially less certain than it appeared six months ago. Gambling always involves risk; regulatory reversal adds a distinct second layer.

Context

Prediction markets — platforms where users trade contracts tied to real-world outcomes — have expanded rapidly under CFTC oversight, with Kalshi and Polymarket among the most prominent examples. As of June 2026, the CFTC has faced sustained pressure from state attorneys general, sports leagues, and now legacy financial institutions who contend that event contracts on elections, sports, and other outcomes require stricter controls or outright prohibition. The CME lawsuit, reported by iGaming Business on 24 June 2026, marks the first time a major incumbent exchange has pursued litigation rather than lobbying alone.

What's Next

The CFTC must respond to the CME's legal filing, a process that could reshape the agency's rulemaking timeline for event contracts through late 2026. Gensler's public opposition may also influence Congressional hearings already scheduled around derivatives market structure reform.

---

Source: iGaming Business, 24 June 2026. Gambling involves financial risk; regulatory changes can affect platform availability without notice.